rubitecan

rubitecan

Oncology A topoisomerase inhibitor in trials for treating ovarian, colorectal, gastric, liver, lung, breast, pancreas, prostate, cervical, head & neck CA, myelodysplastic syndrome, CML, melanoma, glioma, sarcoma